These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3757464)

  • 21. Clinical evidence of the antiarrhythmic effect of a magistral suspension of propafenone: a case report.
    Barranco-Garduño L; Flores-Pérez J; Juárez-Olguín H; Bobadilla-Chávez J; Osnaya H; Flores-Pérez C
    Arch Cardiol Mex; 2009; 79(2):132-4. PubMed ID: 19722384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Medium term study of the efficacy of propafenone in the treatment of hyperkinetic ventricular arrhythmia].
    Cairo GF; Zanni PP; Mascelli G; Zangara A
    Clin Ter; 1989 Jun; 129(5):353-7. PubMed ID: 2527666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine].
    Mondillo S; Faglia S; D'Aprile N; Mangiacotti L; Campolo MA; Agricola E; Palazzuoli V
    Clin Ter; 1995 Dec; 146(12):769-74. PubMed ID: 8681496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Propafenone. An antiarrhythmic agent for both ventricular and supraventricular arrhythmia].
    Madsen JK; Nielsen H; Madsen BK
    Ugeskr Laeger; 1988 Dec; 150(50):3132-3. PubMed ID: 3206724
    [No Abstract]   [Full Text] [Related]  

  • 25. [Worsening of ventricular arrhythmia in the dynamic ECG in patients treated with anti-arrhythmia drugs].
    Lanza GA; Tamburi S; Mondello Malvestiti FM; Rebuzzi AG; Lucente M
    Cardiologia; 1988 Jun; 33(6):613-8. PubMed ID: 3139292
    [No Abstract]   [Full Text] [Related]  

  • 26. Holter monitoring comparative assessment of propafenone and dihydroquinidine efficacy in the treatment of premature ventricular beats.
    Rizzon P; De Toma L; Mangini SG; Scrutinio D; Lagioia R; De Nicolò M
    Cardiologia; 1983 Sep; 28(9):791-801. PubMed ID: 6398703
    [No Abstract]   [Full Text] [Related]  

  • 27. [Importance of programmed ventricular stimulation in the evaluation of proarrhythmic effects of orally administered anti-arrhythmia agents].
    Pleskot M; Pidrman V; Tilser P; Parízek P
    Vnitr Lek; 1995 Sep; 41(9):581-5. PubMed ID: 7483346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Propafenone in the treatment of cardiac arrhythmias].
    Podzolkov VI; Tarzimanova AI
    Kardiologiia; 2012; 52(5):70-3. PubMed ID: 22839589
    [No Abstract]   [Full Text] [Related]  

  • 29. Propafenone (rythmol) for ventricular arrhythmias.
    Porterfield LM
    Adv Clin Care; 1990; 5(5):41. PubMed ID: 2393507
    [No Abstract]   [Full Text] [Related]  

  • 30. [Propafenone on the way into a new world. Profile of the anti-arrhythmia agent].
    Michel D
    Fortschr Med; 1989 Apr; 107(13):81. PubMed ID: 2722109
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experience with the antiarrhythmic propafenone (Rytmonorm)].
    Stejfa M; Spác J; Vítovec J; Havlát F
    Vnitr Lek; 1986 Apr; 32(4):393-7. PubMed ID: 3523975
    [No Abstract]   [Full Text] [Related]  

  • 32. [The anti-arrhythmic effects and electrophysiological actions of propafenone].
    Zheng DS; Wang BY
    Zhonghua Yi Xue Za Zhi; 1985 Jul; 65(7):418-20. PubMed ID: 3938327
    [No Abstract]   [Full Text] [Related]  

  • 33. Propafenone for malignant ventricular arrhythmia: an analysis of the literature.
    Hernandez M; Reder RF; Marinchak RA; Rials SJ; Kowey PR
    Am Heart J; 1991 Apr; 121(4 Pt 1):1178-84. PubMed ID: 2008842
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of the electrophysiologic effects of propafenon in patients with cardiac pre-excitation].
    Disertori M; Vergara G; Inama G; Guarnerio M; Dal Forno P; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(11):1725-8. PubMed ID: 7349232
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical trial of propafenone (rytmonorm) in arrhythmia of patients with ischemic heart disease)].
    Dobrotvorskaia TE; Koroleva ON; Gordina OV; Marakanova AV
    Klin Med (Mosk); 1996; 74(3):51-3. PubMed ID: 8926706
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ambulatory management of ventricular arrhythmias.
    Morganroth J
    Med Times; 1980 Jan; 108(1):42-6. PubMed ID: 7374399
    [No Abstract]   [Full Text] [Related]  

  • 38. [Validity and limits of invasive pharmacological tests in the treatment of malignant ventricular hyperkinetic arrhythmias].
    Disertori M; Vergara G; Inama G; Guarnerio M; Furlanello F; Botti G; Bonatti V; Rolli A
    G Ital Cardiol; 1983; 13(4):311-4. PubMed ID: 6884675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of lidocaine in the treatment of ventricular arrhythmias].
    Antonini FM; Fumagalli C; Bertini G; Ricci F
    Cardiol Prat; 1970 Jun; 21(3):141-54. PubMed ID: 5511551
    [No Abstract]   [Full Text] [Related]  

  • 40. [Low-dose propafenone in chronic ventricular arrhythmia: evaluation by linear regression analysis and correlation with the plasma concentrations of the drug].
    Vitale P; De Stefano R; Perna B; Romano A; Iacono A
    Cardiologia; 1986 Apr; 31(4):303-10. PubMed ID: 3791323
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.